Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Margin of Error01:27

Margin of Error

7.8K
The margin of error is also called the maximum error of an estimate. The margin of error is the maximum possible or expected difference between the observed sample parameter value and the actual population parameter value. For proportion, it is the maximum difference between the value of sample proportion obtained from the data and the true value of population proportion. As the true value of the population parameter is not known, the margin of error is calculated using the sample statistic.
7.8K
Contaminants and Errors01:16

Contaminants and Errors

399
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
399
Confidence Intervals01:21

Confidence Intervals

10.9K
An unbiased point estimate is often insufficient to predict a population estimate, such as population mean or population proportion. In this scenario, a confidence interval is used. A confidence interval is an estimate similar to a  sample proportion. However, unlike the point estimate which is a single value, the confidence interval  contains a range of values. These values have lower and upper limits, known as confidence limits, and can be designated as L1 and L2, respectively.
A...
10.9K
Confidence Interval for Estimating Population Mean01:25

Confidence Interval for Estimating Population Mean

9.0K
A point estimate of the population mean is obtained from a single sample. Such a point estimate does not represent a population well because it needs to account for variability in the population. Single point estimate can also be biased despite the sample being selected randomly. Thus, a point estimate is often unreliable. A confidence interval is needed to reduce this unreliability.
A confidence interval for the mean is a range of values that provides an estimate of the population mean. As the...
9.0K
Sample Size Calculation01:19

Sample Size Calculation

6.8K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
6.8K
Interpretation of Confidence Intervals01:19

Interpretation of Confidence Intervals

10.2K
A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach.

Statistics in medicine·2026
Same author

Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential Trials.

Statistics in medicine·2026
Same author

Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

On Some Modeling Issues in Estimating Vaccine Efficacy.

Pharmaceutical statistics·2024
Same author

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint.

Pharmaceutical statistics·2024
Same author

From populations to networks: Relating diversity indices and frustration in signed graphs.

PNAS nexus·2024

Related Experiment Video

Updated: Feb 20, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.5K

New, Shorter Small-Sample Intervals for Vaccine Efficacy.

Mauro Gasparini1, Vincenzo Di Trani1, Marco Ratta1

  • 1Department of Mathematical Sciences "G.L. Lagrange", Politecnico di Torino, Torino, Italy.

Pharmaceutical Statistics
|February 18, 2026
PubMed
Summary
This summary is machine-generated.

This study presents a Bayesian method to enhance vaccine efficacy (VE) estimation for small to medium sample sizes. The approach improves parameter interval estimation by considering patient recruitment, outperforming traditional methods.

Keywords:
Bayesian methodsincidence ratesmall‐sample asymptoticssurveillance times

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.1K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.5K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.1K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.8K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Trials

Background:

  • Vaccine efficacy (VE) is a critical measure in vaccine research.
  • Current estimation methods may lack precision with small to medium sample sizes.
  • Patient recruitment processes are often overlooked in VE estimation.

Purpose of the Study:

  • To introduce a comprehensive Bayesian approach for improving vaccine efficacy estimation.
  • To develop a method that accounts for patient recruitment in parameter estimation.
  • To enhance the precision of VE estimates, particularly in scenarios with limited data.

Main Methods:

  • A Bayesian statistical framework is proposed.
  • The method incorporates both the number of cases and censored surveillance times.
  • It utilizes first and second moments of surveillance times, irrespective of recruitment strategy.

Main Results:

  • The Bayesian method demonstrates substantial improvements in parameter interval estimation for small to medium sample sizes.
  • Numerical simulations validate enhanced precision across diverse scenarios and recruitment plans.
  • For large sample sizes, the proposed method converges to the maximum likelihood estimation.

Conclusions:

  • The developed Bayesian approach offers a significant improvement for vaccine efficacy estimation with limited data.
  • The methodology is computationally efficient, utilizing Markov Chain Monte Carlo simulations.
  • This work provides a more robust tool for vaccine research, especially in early-stage trials.